Wegovy’s heart benefits are not just linked with weight loss, new study suggests

Recent research indicates that the weight-loss medication Wegovy may offer significant heart benefits beyond its role in reducing body weight. A comprehensive study found that Wegovy lowered the risk of serious heart problems, such as heart attacks and strokes, by 20% among individuals who do not have diabetes but do have heart disease1. This groundbreaking finding suggests that Wegovy could be a valuable treatment for cardiovascular health, independent of its weight loss effects. The study’s results have been so impactful that Novo Nordisk, the maker of Wegovy, has requested the FDA to include these heart benefits on the drug’s label2.